A novel free radical scavenger, NSP-116, ameliorated the brain injury in both ischemic and hemorrhagic stroke models

Reperfusion injury is a serious problem in ischemic stroke therapy, which leads to neuronal damage and intracranial hemorrhage (ICH). A novel free radical scavenger, NSP-116, has anti-oxidative effect and may ameliorate reperfusion injury. The purpose of this study was to investigate the effects of...

Full description

Saved in:
Bibliographic Details
Main Authors: Takahiko Imai (Author), Sena Iwata (Author), Daisuke Miyo (Author), Shinsuke Nakamura (Author), Masamitsu Shimazawa (Author), Hideaki Hara (Author)
Format: Book
Published: Elsevier, 2019-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8c7d2c524c5b4af0a61ba28b3732b68a
042 |a dc 
100 1 0 |a Takahiko Imai  |e author 
700 1 0 |a Sena Iwata  |e author 
700 1 0 |a Daisuke Miyo  |e author 
700 1 0 |a Shinsuke Nakamura  |e author 
700 1 0 |a Masamitsu Shimazawa  |e author 
700 1 0 |a Hideaki Hara  |e author 
245 0 0 |a A novel free radical scavenger, NSP-116, ameliorated the brain injury in both ischemic and hemorrhagic stroke models 
260 |b Elsevier,   |c 2019-11-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1016/j.jphs.2019.09.012 
520 |a Reperfusion injury is a serious problem in ischemic stroke therapy, which leads to neuronal damage and intracranial hemorrhage (ICH). A novel free radical scavenger, NSP-116, has anti-oxidative effect and may ameliorate reperfusion injury. The purpose of this study was to investigate the effects of NSP-116 on both ischemic and hemorrhagic stroke models.First, we assessed whether NSP-116 has protective effects in vitro. Pre-treatment of NSP-116 decreased neuronal cell damage induced by H2O2 or LPS. Moreover, NSP-116 also suppressed mitochondria damage and apoptosis in H2O2-induced neuronal injury model. Based on these results, we used a middle cerebral artery occlusion (MCAO)-induced ischemic stroke model or a collagenase-induced ICH model. Using the MCAO model, we evaluated the cerebral blood flow (CBF), neurological deficit, and infarct volume. Hematoma volume was assessed at 3 days after ICH. In the MCAO model, oral administration of NSP-116 at 30 mg/kg attenuated the reduction of CBF, neurological deficits, and infarct formation. Interestingly, NSP-116 also ameliorated hematoma expansion and neurological deficits in the ICH model. Additionally, pre-treatment of NSP-116 suppressed the brain microvascular endothelial cell death induced by collagenase treatment.Collectively, our findings indicated that oral administration of NSP-116 attenuates both ischemic and hemorrhagic brain injuries after stroke. Keywords: Brain hemorrhage, Brain ischemia, Oxidative stress, A free radical scavenger, Stroke 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 141, Iss 3, Pp 119-126 (2019) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861319357159 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/8c7d2c524c5b4af0a61ba28b3732b68a  |z Connect to this object online.